A Study of KW-0761 in Subjects With HTLV-1 Associated Myelopathy (HAM)

NCT03191526 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

66

Enrollment

INDUSTRY

Sponsor class

Stopped Due to not achieving the primary outcome.

Conditions

HTLV-1 Associated Myelopathy

Interventions

DRUG: KW-0761 0.3 mg/kg IV
DRUG: Placebo (saline)

Sponsor

Kyowa Kirin Co., Ltd.